BNT-325 is under clinical development by BioNTech and currently in Phase II for Non-Small Cell Lung Cancer. According to GlobalData, Phase II drugs for Non-Small Cell Lung Cancer have a 38% phase ...

Identifying lung cancer at its earliest stage before symptoms develop allows for earlier treatment and the potential for cure ...

The following is a summary of “Palliative endoscopic treatment of malignant central airway obstruction,” published in the ...

PM-8002 is under clinical development by Biotheus and currently in Phase II for Small-Cell Lung Cancer. According to GlobalData, Phase II drugs for Small-Cell Lung Cancer have a 26% phase transition ...

Greg Gumbel, Bryant Gumbel's brother and former CBS Sports anchor and commentator, has passed away. He was 78. An official ...

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announced the results of a large-scale study which shows that its Nu.Q® Cancer Test differentiated ...

A surgical team at Dr Bhimrao Ambedkar Memorial Hospital in Raipur has successfully removed a 5kg mediastinal tumour from a ...

Hanx Biopharmaceuticals, CO. Ltd, an innovative biotechnology company developing next-generation immunotherapies to address the challenges of unmet medical need diseases, today announced the first ...